Association of Low Serum Bilirubin Concentrations and Promoter Variations in the UGT1A1 and HMOX1 Genes with Type 2 Diabetes Mellitus in the Czech Population
Abstrakt
Bilirubin has potent biological beneficial effects, protecting against atherosclerosis, obesity, and metabolic syndrome. The aim of this study was to assess serum bilirubin concentrations and (TA)(n) and (GT)(n) microsatellite variations in the promoter regions of the UGT1A1 and HMOX1 genes, respectively, in patients with type 2 diabetes mellitus (T2DM).
The study was carried out in 220 patients with T2DM and 231 healthy control subjects, in whom standard biochemical tests were performed. The (TA)(n) and (GT)(n) dinucleotide variations were determined by means of fragment (size-based) analysis using an automated capillary DNA sequencer.
Compared to controls, both male and female patients with T2DM had lower serum bilirubin concentrations (9.9 vs. 12.9 & mu;mol/L, and 9.0 vs. 10.6 & mu;mol/L, in men and women, respectively, p < 0.001). Phenotypic Gilbert syndrome was much less prevalent in T2DM patients, as was the frequency of the (TA)(7/7) UGT1A1 genotype in male T2DM patients. (GT)(n) HMOX1 genetic variations did not differ between diabetic patients and controls.
Our results demonstrate that the manifestation of T2DM is associated with lower serum bilirubin concentrations. Consumption of bilirubin due to increased oxidative stress associated with T2DM seems to be the main explanation, although (TA)(n) repeat variations in UGT1A1 partially contribute to this phenomenon.
